Trump Trade: White House launches space nuclear initiative

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly.

Claim 55% Off TipRanks

SPACE NUCLEAR POWER: Shares of nuclear names including Oklo (OKLO) and NuScale (SMR) moved higher Thursday following a sweeping White House directive aimed at deploying American reactor tech in space and on the Moon. The White House Office of Science and Technology Policy issued the memorandum on April 14, formally launching the National Initiative for American Space Nuclear Power and setting targets for reactors in orbit by 2028 and on the Moon by 2030.

WEAPONS: The Trump administration is seeking to have car makers and other major American manufacturers play a larger role in making weapons, similar to a practice used during World War II, the Wall Street Journal’s Sharon Terlep and Marcus Weisgerber report. Senior defense officials have held discussions about making weapons and other military supplies with top executives of several companies, including General Motors (GM) CEO Mary Barra and Ford (F) CEO Jim Farley, the authors say, citing people familiar with the talks.

DRUGMAKERS STILL RAISES PRICES: A report led by Senator Bernie Sanders found that prescription drug prices have continued to rise despite prior pricing agreements with President Donald Trump, with some medications seeing significant increases and new drugs launching at very high annual costs, NBC News’ Berkeley Lovelace Jr. reports. The findings highlight ongoing challenges in controlling U.S. drug pricing ahead of a Senate hearing on the issue. Publicly traded companies in the space include AstraZeneca (AZN), Bristol Myers (BMY), Eli Lilly (LLY), GSK (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).